Company Filing History:
4 out of 6 
3 out of 3 
2 out of 5 
Years Active: 1991-2023
Title: Gerard Tiraby: Innovator in Cyclic Dinucleotide Research
Introduction
Gerard Tiraby is a notable inventor based in Toulouse, France. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of cyclic dinucleotides for cytokine induction. With a total of 11 patents to his name, Tiraby's work has implications for treating various infections and cancers.
Latest Patents
One of his latest patents involves a cyclic dinucleotide compound designed for cytokine induction. The compound is characterized by a specific formula where X can be either H or F, with at least one of the X atoms being a fluorine atom. The compound also includes a component Z, which can be OH, OR, SH, or SR, and R can be Na or NH, or an enzyme-labile group that provides OH or SH in vivo. The bases used in the compound are chosen from Adenine, Hypoxanthine, or Guanine, with B being a different base than A, along with a pharmaceutically acceptable salt. This invention also describes pharmaceutical compositions that utilize the cyclic dinucleotide for treating bacterial infections, viral infections, or cancer.
Career Highlights
Throughout his career, Gerard Tiraby has worked with several prominent companies in the biotechnology sector. Notable among these are Invivogen and Kayla Therapeutics, where he has contributed to innovative research and development projects. His work has been instrumental in advancing the understanding and application of cyclic dinucleotides in medicine.
Collaborations
Gerard has collaborated with several professionals in his field, including Daniel Drocourt and Thierry Lioux. These collaborations have further enriched his research and have led to significant advancements in the applications of his inventions.
Conclusion
Gerard Tiraby's contributions to the field of cyclic dinucleotide research highlight his role as an influential inventor. His innovative patents and collaborations continue to pave the way for advancements in medical treatments.